Cargando…
Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease
BACKGROUND: Fatty acid-binding protein 4 (FABP4) (also known as adipocyte FABP or adipocyte P2) is expressed in adipocytes, macrophages, and capillary endothelial cells. Previous studies have shown associations among plasma FABP4, insulin resistance, metabolic syndrome, diabetes mellitus, greater co...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591904/ https://www.ncbi.nlm.nih.gov/pubmed/31234795 http://dx.doi.org/10.1186/s12872-019-1134-z |
_version_ | 1783429802779213824 |
---|---|
author | Wang, Chao-Ping Hsu, Chia-Chang Hung, Wei-Chin Yu, Teng-Hung Wu, Cheng-Ching Tsai, I-Ting Tang, Wei-Hua Chung, Fu-Mei Houng, Jer-Yiing Lee, Yau-Jiunn Lu, Yung-Chuan |
author_facet | Wang, Chao-Ping Hsu, Chia-Chang Hung, Wei-Chin Yu, Teng-Hung Wu, Cheng-Ching Tsai, I-Ting Tang, Wei-Hua Chung, Fu-Mei Houng, Jer-Yiing Lee, Yau-Jiunn Lu, Yung-Chuan |
author_sort | Wang, Chao-Ping |
collection | PubMed |
description | BACKGROUND: Fatty acid-binding protein 4 (FABP4) (also known as adipocyte FABP or adipocyte P2) is expressed in adipocytes, macrophages, and capillary endothelial cells. Previous studies have shown associations among plasma FABP4, insulin resistance, metabolic syndrome, diabetes mellitus, greater coronary plaque burden, coronary artery disease, heart failure, and mortality. However, little is known about the relationship between FABP4 level and prolonged QT interval. The aim of this study was to investigate whether plasma FABP4 level is associated with a prolonged QT interval by analyzing 12-lead electrocardiograms (ECGs) in patients with stable angina and chronic kidney disease (CKD). METHODS: This study included 397 consecutive patients with stable angina and CKD who were enrolled in a disease management program. Plasma FABP4 concentrations were measured using enzyme-linked immunosorbent assays. A 12-lead ECG recording was obtained from each patient. We assessed the relationships between FABP4 levels (both as a continuous variable and stratified by tertile) at admission and corrected QT (QTc) prolongation. RESULTS: Patients with an abnormal QTc interval had higher median plasma FABP4 levels than those with borderline and normal QTc intervals (15.9 ng/mL vs. 10.2 ng/mL vs. 8.5 ng/mL, respectively, P < 0.0001). Statistically significant associations were observed between plasma FABP4 levels and QTc interval (β = 0.267, P < 0.0001). Using multivariate and trend analyses, a higher concentration of plasma FABP4 level was independently associated with QTc prolongation in patients with stable angina and CKD. CONCLUSION: In this study, plasma FABP4 levels were significantly higher in the patients with an abnormal QTc interval and were correlated with QTc prolongation. Further studies are required to elucidate whether plasma FABP4 plays a role in the pathogenesis of QTc prolongation. |
format | Online Article Text |
id | pubmed-6591904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65919042019-07-08 Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease Wang, Chao-Ping Hsu, Chia-Chang Hung, Wei-Chin Yu, Teng-Hung Wu, Cheng-Ching Tsai, I-Ting Tang, Wei-Hua Chung, Fu-Mei Houng, Jer-Yiing Lee, Yau-Jiunn Lu, Yung-Chuan BMC Cardiovasc Disord Research Article BACKGROUND: Fatty acid-binding protein 4 (FABP4) (also known as adipocyte FABP or adipocyte P2) is expressed in adipocytes, macrophages, and capillary endothelial cells. Previous studies have shown associations among plasma FABP4, insulin resistance, metabolic syndrome, diabetes mellitus, greater coronary plaque burden, coronary artery disease, heart failure, and mortality. However, little is known about the relationship between FABP4 level and prolonged QT interval. The aim of this study was to investigate whether plasma FABP4 level is associated with a prolonged QT interval by analyzing 12-lead electrocardiograms (ECGs) in patients with stable angina and chronic kidney disease (CKD). METHODS: This study included 397 consecutive patients with stable angina and CKD who were enrolled in a disease management program. Plasma FABP4 concentrations were measured using enzyme-linked immunosorbent assays. A 12-lead ECG recording was obtained from each patient. We assessed the relationships between FABP4 levels (both as a continuous variable and stratified by tertile) at admission and corrected QT (QTc) prolongation. RESULTS: Patients with an abnormal QTc interval had higher median plasma FABP4 levels than those with borderline and normal QTc intervals (15.9 ng/mL vs. 10.2 ng/mL vs. 8.5 ng/mL, respectively, P < 0.0001). Statistically significant associations were observed between plasma FABP4 levels and QTc interval (β = 0.267, P < 0.0001). Using multivariate and trend analyses, a higher concentration of plasma FABP4 level was independently associated with QTc prolongation in patients with stable angina and CKD. CONCLUSION: In this study, plasma FABP4 levels were significantly higher in the patients with an abnormal QTc interval and were correlated with QTc prolongation. Further studies are required to elucidate whether plasma FABP4 plays a role in the pathogenesis of QTc prolongation. BioMed Central 2019-06-24 /pmc/articles/PMC6591904/ /pubmed/31234795 http://dx.doi.org/10.1186/s12872-019-1134-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wang, Chao-Ping Hsu, Chia-Chang Hung, Wei-Chin Yu, Teng-Hung Wu, Cheng-Ching Tsai, I-Ting Tang, Wei-Hua Chung, Fu-Mei Houng, Jer-Yiing Lee, Yau-Jiunn Lu, Yung-Chuan Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
title | Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
title_full | Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
title_fullStr | Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
title_full_unstemmed | Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
title_short | Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
title_sort | plasma fatty acid-binding protein 4 (fabp4) level is associated with abnormal qtc interval in patients with stable angina and chronic kidney disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591904/ https://www.ncbi.nlm.nih.gov/pubmed/31234795 http://dx.doi.org/10.1186/s12872-019-1134-z |
work_keys_str_mv | AT wangchaoping plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT hsuchiachang plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT hungweichin plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT yutenghung plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT wuchengching plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT tsaiiting plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT tangweihua plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT chungfumei plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT houngjeryiing plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT leeyaujiunn plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease AT luyungchuan plasmafattyacidbindingprotein4fabp4levelisassociatedwithabnormalqtcintervalinpatientswithstableanginaandchronickidneydisease |